Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
申请人:Mayo Foundation for Medical Educational and Research
公开号:US20140309185A1
公开(公告)日:2014-10-16
This document relates to inhibitors of G protein coupled receptor 6 kinase (GRK6) polypeptides as well as methods and materials for using such inhibitors to treat hematological malignancies, inflammation diseases, and autoimmune disorders.
Inhibiting G protein coupled receptor 6 kinase polypeptides
申请人:Mayo Foundation for Medical Education and Research
公开号:US10252984B2
公开(公告)日:2019-04-09
This document relates to inhibitors of G protein coupled receptor 6 kinase (GRK6) polypeptides as well as methods and materials for using such inhibitors to treat hematological malignancies, inflammation diseases, and autoimmune disorders.
本文件涉及 G 蛋白偶联受体 6 激酶(GRK6)多肽的抑制剂以及使用这种抑制剂治疗血液恶性肿瘤、炎症疾病和自身免疫性疾病的方法和材料。
[EN] INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES<br/>[FR] INHIBITION DE POLYPEPTIDES DE RÉCEPTEURS 6 KINASES COUPLÉS À UNE PROTÉINE G
申请人:MAYO FOUNDATION
公开号:WO2013063458A2
公开(公告)日:2013-05-02
This document relates to inhibitors of G protein coupled receptor 6 kinase (GRK6) polypeptides as well as methods and materials for using such inhibitors to treat hematological malignancies, inflammation diseases, and autoimmune disorders.
Synthesis, Structure-Activity Relationship (SAR) Studies on some 4-Aryl-4Hchromenes and Relationship between Lipophilicity and Antitumor Activity
作者:Ahmed El-Agrody、Essam A. E. H. Khattab、Ahmed Fouda
DOI:10.2174/1570180811666140623204655
日期:2014.10.1
Some 4-aryl-4H-chromenes 3a-h, 5a-g, 7a-g and 9a-g were obtained by reaction of 3-substituted phenol 1, 4, 6
and 8 with α-cyanocinnamonitrile derivatives 2. We explored the structure activity relationship (SAR) of 4-aryl-4Hchromenes
with modification at the 4- and 7-positions. The antitumor activity of the synthesized compounds was investigated
in comparison with the standard drugs Vinblastine and Doxorubicin using microculture tetrazolium (MTT) colorimetric assay.
Some compounds were found to have good in vitro antitumor activity. The structure-activity relationship (SAR) study
revealed that the antitumor activity of 4-aryl-4H-chromenes was significantly affected by the lipophilicity, the calculated Log
P value and the balance between 7-hydrophilic or hydrophobic substituent and hydrophobic substituent on the benzene ring at
4-position. The structures of the newly prepared compounds were confirmed by elemental analysis and spectral data.